Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

[Antibiotic treatment for acute episodes of chronic obstructive pulmonary disease].

Alonso Martínez JL, Rubio Obanos MT, Sampériz Legarre AL, Escolar Castellón F, Carrasco del Amo ME.

An Med Interna. 1992 Aug;9(8):377-80. Spanish.

PMID:
1391559
3.

Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.

Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.

Pediatrics. 2004 Oct;114(4):e469-76.

PMID:
15466073
4.
5.

Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.

Llor C, Hernández S, Ribas A, Alvarez C, Cots JM, Bayona C, González I, Miravitlles M; BRAMOX Study Group..

Int J Chron Obstruct Pulmon Dis. 2009;4:45-53. Epub 2009 Apr 15.

6.
7.

Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.

Bansal A, Singhi SC, Jayashree M.

Indian J Pediatr. 2006 Apr;73(4):305-9.

PMID:
16816491
8.

Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.

Brusse-Keizer M, ten Bokum L, Movig K, van der Valk P, Kerstjens H, van der Palen J, Hendrix R.

COPD. 2011 Apr;8(2):66-70. doi: 10.3109/15412555.2011.558863.

PMID:
21495834
9.

Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).

Sportel JH, Koëter GH, van Altena R, Löwenberg A, Boersma WG.

Thorax. 1995 Mar;50(3):249-53.

10.

Antimicrobial management of acute exacerbation of chronic airflow limitation.

Davies L, Hadcroft J, Mutton K, Earis JE, Kennedy N.

QJM. 2001 Jul;94(7):373-8.

PMID:
11435633
11.

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA.

Ann Intern Med. 1987 Feb;106(2):196-204.

PMID:
3492164
12.

The role of infection in acute exacerbations of chronic obstructive pulmonary disease.

Hillberg RE.

Am J Manag Care. 2000 May;6(8 Suppl):S427-36. Review.

13.

Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.

Miravitlles M, Llor C, Naberan K, Cots JM, Molina J; EFEMAP study group..

Respir Med. 2005 Aug;99(8):955-65.

14.

Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.

Brusse-Keizer M, VanderValk P, van der Zanden RW, Nijdam L, van der Palen J, Hendrix R, Movig K.

Int J Chron Obstruct Pulmon Dis. 2015 Mar 3;10:455-61. doi: 10.2147/COPD.S70355. eCollection 2015.

15.

Microbiology of acute otitis media recently treated with aminopenicillins.

Block SL, Hedrick JA, Tyler RD, Smith RA, Harrison CJ.

Pediatr Infect Dis J. 2001 Nov;20(11):1017-21.

PMID:
11734704
16.

[Treatment effects of co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: clinical evaluation].

Andrijević I, Povazan D, Andrijević L, Povazan A, Milutinov S.

Med Pregl. 2011 Mar-Apr;64(3-4):178-82. Serbian.

PMID:
21905596
17.

Antibiotics in the treatment of acute exacerbations of chronic bronchitis.

Dever LL, Shashikumar K, Johanson WG Jr.

Expert Opin Investig Drugs. 2002 Jul;11(7):911-25. Review.

PMID:
12084002
18.

Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.

Allegra L, Konietzko N, Leophonte P, Hosie J, Pauwels R, Guyen JN, Petitpretz P.

J Antimicrob Chemother. 1996 May;37 Suppl A:93-104.

PMID:
8737129
19.
20.

Severe exacerbations of COPD patients: the role of pulmonary infections.

Fagon JY, Chastre J.

Semin Respir Infect. 1996 Jun;11(2):109-18. Review.

PMID:
8776780

Supplemental Content

Support Center